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CHELATING COMPOUNDS AND 
IMMOBILIZED TETHERED CHELATORS 
TECHNICAL FIELD AND INDUSTRIAL 
APPLICABILITY OF THE INVENTION 
The present invention relates generally to the chemical 
?eld and, more particularly, to novel chelating agents, useful 
intermediates for synthesizing those chelating agents, the 
immobilization of those agents on a solid support resin, and 
the use of those chelating resins to remove metal ions from 
aqueous solutions. 
BACKGROUND OF THE INVENTION 
A chelator or chelating agent is a polydentate ligand that 
bonds to more than one coordination site of a metal ion. 
Chelating agents have long been knoWn in the art to be useful 
in chemical analysis, in environmental remediation and in 
medicine. In chelation therapy, a chelating agent is employed 
to bind a poisonous metal agent such as mercury, arsenic, 
iron, lead or aluminum in order to displace the ion from 
biological ligands such as proteins and convert the metal ion 
into a less toxic form that can be excreted Without further 
interaction With the body. 
The present invention relates to (1) novel chelating agents 
or compounds, (2) novel immobiliZed, tethered chelators 
comprising the novel chelating compounds linked to immo 
biliZed supports and (3) methods of employing the novel 
compounds and chelators to remove trivalent metals such as 
Al3+ from aqueous systems in situ, in vivo and in vitro. 
There have been previous studies of tripodal, trihydrox 
amic acids. Most of these ligands are based on tripodal plat 
forms of tris(2-aminethyl)amine(tren) (Matsumoto et al., 
Chem. Commun. 2001, 978-979; Matsumoto et al., Inorg. 
Chem., 2001, 40: 190-191; Matsumoto et al., Inorg. Chem, 
2004, 43: 8538-8546; Ng et al., Inorg. Chem. 1989, 28: 2062 
2066), tris(3-aminopropyl)amine (Matsumoto et al., Eur. J. 
Inorg. Chem, 2001, 2481-2484); or nitrilotriacetic acid (nta) 
(Lee et al, J. Med. Chem. 1985, 28: 317-323; Hara et al., 
Inorg. Chem. 2000, 39: 5074-5082). These studies teach that 
such ligands form Fe3+ complexes With binding constants in 
the range of 1028 to 1033, so long as there are ?ve or six atoms 
connecting the bridgehead atom of the platform and the ?rst 
atom of the hydroxamate functional group on the sidearm 
(Matsumoto et al., Eur. J. Inorg. Chem. 2001, 2481-2484; 
Matsumoto et al., Inorg. Chem. 2001, 40: 190-191; Ng et al., 
Inorg. Chem. 1989, 28: 2062-2066). These ligands include 
amide functional groups in the sidearms, and the iron com 
plexes appear to be stabiliZed by intramolecular hydrogen 
bonding betWeen the amide functional groups (Matsumoto et 
al., Inorg. Chem. 2001, 40:190-191). 
The common feature of all the above ligands is that the 
bridgehead atom is a tertiary nitrogen. To attach these ligands 
to a solid support via this nitrogen Would require the forrna 
tion of a quaternary ammonium group. This is expected to 
have an adverse effect on the chelating ability of the ligand. It 
Will introduce a permanent positive charge on the ligand, 
resulting in electrostatic repulsion of the target metal ion. In 
some cases, it Will also require a change in the conformation 
of the metal complex. 
A feW tripodal tris(hydroxamate) ligands have been pre 
pared in Which the bridgehead atom is a carbon, rather than a 
nitrogen. These ligands are built on tripodal bases of either 
1,1,1-tris(hydroxymethyl)ethane (Motekaitis et al., Inorg. 
Chem. 1991, 30: 1554-1556) or 1,1,1-tris(hydroxymethyl) 
propane (Dayan et al., Inorg. Chem. 1993, 32: 1467-1475). 
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2 
Hydroxamate groups Were added to these tripodal bases 
through ether linkages. These studies teach that one needs 4 or 
5 atoms betWeen the bridgehead carbon and the ?rst atom of 
the hydroxamate functional group for strong metal binding. 
The Fe3+ complexes of these ligands have binding constants 
of 1026 to 1028. HoWever, it is not possible to link these 
ligands to a polymeric support through the quaternary carbon 
bridgehead atom. 
The current invention is based in the use of hydroxyalky 
laminomethanes, especially the common buffer tris(1 ,1 ,1 -tris 
(hydroxymethyl)aminomethane), as the tripodal base. The 
use of hydroxylalkylaminomethanes alloWs us to construct 
tripodal chelating functional groups that Will mimic the high 
metal binding a?inities of the ligands already in the literature, 
but it also provides a free amine group that can be used to 
easily attach the ligands to a variety of solid support. 
SUMMARY OF THE INVENTION 
In accordance With the purposes of the present invention as 
described herein, novel di- and tripodal compounds are dis 
closed for use as chelating agents. Such compounds include, 
but are not limited to, novel tripodal trihydroxamate chelating 
agents having a tris(hydroxylalky)aminomethane platform, 
such chelating agents bonded to a polymeric resin, useful 
intermediates for making such chelating agents and to a 
method of removing aluminum from a solution using such 
chelating agents. 
In the folloWing description there is shoWn and described 
several different embodiments of the invention, simply by 
Way of illustration of some of the modes best suited to carry 
out the invention. As it Will be realiZed, the invention is 
capable of other different embodiments and its several details 
are capable of modi?cation in various, obvious aspects all 
Without departing from the invention. Accordingly, the draW 
ings and descriptions Will be regarded as illustrative in nature 
and not as restrictive. 
BRIEF DESCRIPTION OF THE DRAWINGS 
The accompanying draWings, incorporated herein and 
forming a part of the speci?cation, illustrate several aspects of 
the present invention and together With the description serve 
to explain certain principles of the invention. In the draWings: 
FIG. 1 is a linear free energy relationship shoWing the 
correlation betWeen the binding a?inities of Fe3+ and Al3+ 
With hydroxamate ligands. Each data point represents a 
ligand, With the log [3 value for Fe3+ as the x-coordinate and 
the log [3 value forAl3+ as the y-coordinate. The open symbols 
represent reference compounds described in the literature. 
The data points are: 1-3 represent the 1:1, 1:2, and 1:3 com 
plexes With acetohydroxamic acid. Points 4-7 represent a 
series of linear dihydroxamates, in Which the hydroxamate 
groups are separated by 4, 5, 6, or 7 methylene groups. Points 
8 and 9 are the binding constants of the DFO complexes and 
the protonated complexes of DFO. Point 10 is mesitylenetri 
hydroxamic acid. The ?lled triangles represent compounds 
from the current invention. Point 11 represents the complexes 
of Ligand 1, point 12 represents the protonated complexes of 
Ligand 1, and point 13 represents the complexes of Ligand 7. 
FIG. 2 is a graph demonstrating the binding of Al3 + to 50 
mg Resin 1 in Which the concentration of free Al3+ remaining 
in solution after the addition of 50 mcg A1 at time 0 to either 
100 ml or 5 ml of 4-morpholineethanesulfonic acid (MES) 
buffer at pH 5 has been determined by electrothermal atomic 
absorption spectroscopy (ETAAS). 
US 7,932,326 B2 
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FIG. 3 is a spectrophotometry assay showing the binding of 
Al3+ to Resin 1 following addition of 22.8 mg of Resin 1 to 3 
ml of 0.15 mM Al-ferron at pH 5. Spectra shoW the decrease 
in the absorbance of Al-ferron at 364 nm and the increase in 
the absorbance of free ferron at 434 nm. Spectrum 10 shoWs 
the reference spectrum for 0.15 mM ferron. 
FIG. 4 is a graph illustrating the binding of Al3 + to Resin 1 
folloWing the sequential addition of six aliquots of 100 mcg of 
Al to 50 mg of Resin 1 suspended in 100 ml of pH 5 MES 
buffer. The ?rst aliquot of Al Was added at time:0. Five 
subsequent additions Were made at 12 hr intervals at the time 
indicated by the arroWs on the graph. The free Al concentra 
tion Was determined by ETAAS; and 
FIG. 5 is a graph illustrating the binding of Al3 + to Resin 1 
folloWing the addition of 250 mg of Resin 1 to 0.5 ml of 
0.23M calcium gluconate containing ~9000 ng Al/ml. The 
free Al concentration Was determined by ETAAS. 
DETAILED DESCRIPTION OF THE PREFERRED 
EMBODIMENTS OF THE INVENTION 
The present invention relates generally to novel chelating 
compounds having a general formula of 
R2 
Wherein R1:hydrogen or tosylate, R2:hydrogen, methyl, 
ethyl, n-propyl or isopropyl and 
Wherein x, y, and Z vary independently from 2 to 4, and 
R4:hydrogen or C l-C 10 straight or branched alkyl; 
o 
o IlI_C// bong; \R4 
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Wherein x, y, and Z vary independently from 2 to 4 and 
R4:hydrogen or C l-C 10 straight or branched alkyl; 
0) 
o CON(R4)OH 
Wherein R4:hydrogen or Cl-C1O straight or branched alkyl; 
d.) 
{common CON(R4)OH o / \ 
0 OJ 
0 o—\ 
\—/ CON(R4)OH 
Wherein R4:hydrogen or Cl-C1O straight or branched alkyl; 
e.) 
O O 
on 
(CR52)n / 
/ N 
0 
R4 
0 
OQL /(CR52)n OH 
NH O / 
o N 
N\H % /OH \ 4 
(CR2). N R 
US 7,932,326 B2 
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wherein n:2 or 3, R5 :hydro gen or methyl, and R4:hydro gen 
or C l-C 10 straight or branched alkyl; 
f-) 
O OH 
H 
C_ 
R4 
R4 
/ 
O C—N 
(ll on 
o 
o 
O OH 
H 
C_ 
R4 
Wherein R4:hydrogen or C l-C 10 straight or branched alkyl; 
g) 
Wherein R4:hydrogen or Cl-Cl0 straight or branched alkyl; 
and 
h.) 
OH 
R4 
Wherein R5 :hydro gen or methyl and R4:hydrogen or C 1 -C 1 0 
straight or branched alkyl. 
The novel compounds of the present invention are particu 
larly useful as chelators or chelating agents. One preferred 
use of the free ligands Would be in vivo chelation therapy to 
remove metal ions such as Fe3+ and Al3+ from the body. 
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The compounds include an amine functional group that 
alloWs the ligands to be easily linked to an insoluble matrix 
via a sulfonamide linkage, an amide linkage or a urea linkage 
to provide immobilized, tethered chelators. Typically, the 
insoluble matrix comprises a resin support. The resin support 
may take the form of a macro-porous polystyrene such as 
commercially available under the trademark XAD-4 sold by 
Rohm and Haas. Other polymer resins useful in the present 
invention include but are not limited to, polyacrylate, 
sepharose and silica gel. 
The overall process of adding a chelating compound of the 
present invention to a polystyrene resin via a sulfonamide 
bond is shoWn in Scheme 1, Where NRzH-Ligand in this and 
subsequent schemes refers to the free amine form (R1:H; 
R2:hydrogen, methyl, ethyl, n-propyl or isopropyl) of any of 
the free ligands represented by R3:a through h. 
Scheme 1 
INSOLUBLE C130; H 
MATRIX 
macroporous 
polystyrene resin, 
e.g. XAD-4 
ii NH-Li and INS OLUBLE S _ 0 g 
MATRIX EtN, THF 
modi?ed resin 
INS OLUBLE 
MATRIX 
res in 
linker 
The overall process of adding a chelating compound of the 
present invention to a resin support by means of an amide 
linkage is shoWn in Scheme 2. 
Scheme 2 
The overall process of adding a chelating compound of the 
present invention to a resin support by means of a urea linkage 
is shoWn in Scheme 3. 
INSOLUBLE 
MATRIX 
INSOLUBLE 
MATRIX 
US 7,932,326 B2 
Scheme} 
O—> 
NH2 0 
N—o / 
O 2 
O O ET3N, THF 
M O i HRZN-Ligemd 
NH o— N 
O 
% O i NH NRZ-Ligemd 
For certain applications it may be desirable to elongate the Other commercially available amine-capped polyethyl 
linker by adding polyethylene glycol units betWeen the resin 25 eneglycols include the compounds 
support and the ligand in order to increase the rate of metal 
binding to the resin-bound ligand. These elongated linkers are 
added using commercially available amine capped polyeth 
ylene glycols of variable length, With the use of a urea func- O/(VOWNHZ )2 
tional group to covalently bind the ligand and linker moieties. 30 
The elongation process is illustrated in Scheme 4 using the 
linker 3-oXa-l,5-pentanediamine as a speci?c example. 
O 
u o 
m s—N/\/ \/\NH. 
u H O 
O /O 
N—O 
O 2 
O O 
O i 0 mm LN/V \/\NH O_N % 
H H HRZN-Ligemd 
O 
O 
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-continued 
CH3 
Mow NH2 H3N n o 
5 
CH3 
n I 10-12 
Which give chelating resins With the structures shown below 
0 
Insoluble Matrix 
CH3 
Insoluble Matrix 
NH NRz-Ligand 
CH3 
n :10-12 
The immobilized, tethered chelators of the present inven- 25 
tion comprise the chelating compounds identi?ed above 
bound to a resin support through an appropriate linkage. The 
immobiliZed, tethered chelators of the present invention may 
be generally described as having the folloWing formula: 
30 
R6— III — R3 
R2 
35 
Wherein R6: 
Insoluble 
Matrix 
Insoluble 
Matrix 
Insoluble 
Matrix 
O 
Insoluble Cl 
Matrix / \ 
US 7,932,326 B2 
5..) 
1 1 
R2:hydr0gen, methyl, ethyl; n-propyl 0r isopropyl and 
R3: 
O OH 
\\C—N 
/ 4 
(CHDX R OH 
\O /<CH2>y\|| / 
O \ 4 
O OH R 
l N/ O _ 
/ \ 
(CH2); R4 
wherein x, y, and Z Vary independently from 2 t0 4 and 
R4:hydr0gen or C l-C 10 straight or branched alkyl; 
b.) 
Wherein x, y, and Z Vary independently from 2 t0 4, and 
R4:hydr0gen or C l-C 10 straight or branched alkyl; 
0 CON(R4)OH 
0.) 
wherein R4:hydr0gen or C l-C 10 straight or branched alkyl; 
KO NJ 
0 O 
O O 
d.) 
12 
Wherein R4:hydr0gen 0r Cl-C1O straight or branched alkyl; 
e.) 
5 O 
0 (CR5 ) /OH 
N14 2 n 
0 \R4 
10 0 
CR5 
0% /( 2)n\< H NH
O O \ 
4 
Nil OH R 
15 5 
(CR 2)” N 
0 
wherein n:2 0r 3, R5 :hydro gen or methyl, and R4:hydr0 gen 
or C l-C 10 straight or branched alkyl; 
25 
c N/ 30 — 
\R4 
0 N/ O _ 
35 (ll \OH 
0 
0 
40 
O OH 
H / 
C—N 
\ 
R4 
45 
Wherein R4:hydr0gen 0r Cl-C1O straight or branched alkyl; 
60 
65 
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wherein R4:hydrogen or Cl-Cl0 straight or branched alkyl; 
and 
h.) 
Wherein R5 :hydro gen or methyl and R4:hydrogen or C 1 -C 1 0 
straight or branched alkyl. 
Preparation of Compounds of this Invention 
Selected chelating agents and chelating resins from this 
invention are listed in Table 1. 
TABLE 1 
Partial list of chelating agents and 
chelating resins included in this invention 
R5 R3 x y Z R2 
Free Ligands (R1 : Tosyl, R4 I H) R1— N—R3 
R2 
Ligand 
Ligand l a 2 2 2 H 
Ligand 2 a 3 3 3 H 
Ligand 3 a 4 4 4 H 
Ligand 4 a 4 4 2 H 
Ligand 5 c H 
Ligand 6 d H 
Ligand 7 h Methyl 
Ligand 8 a 3 3 2 H 
Ligand 9 g 
Resins (R6 I polystyrenesulfonate, R4 I H) R6—N—R3 
R2 
Resin 1 a 2 2 2 H 
Resin 2 h Methyl 
EXAMPLE 1 
Synthesis of Ligand 1 
The overall synthesis of Ligand 1 is shoWn in Scheme 5. 
The aminotriol (1, Tris buffer) Was reacted With acrylonitrile 
in the presence of a catalytic amount of base to give the 
trinitrile (Intermediate I) (NeWkome, G. R. and X. Lin, Sym 
metrical, four-directional, p0ly(eZher-amide) cascade poly 
mers. Macromolecules, 1991, 24(6): 1443 -1444). Reaction of 
Intermediate 1 in re?uxing methanolic HCl gave the tris(m 
ethyl ester) (Intermediate 2). Reaction of Intermediate 2 With 
tosyl chloride gave the sulfonamide tris ester (Intermediate 
3). This ester Was converted to the trihydroxamic acid (Ligand 
1) by reaction With O-trimethylsilyl hydroxylamine in metha 
nol. 
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Scheme 5 
OH 
dioxane, KOH cat) 
HZN OH —>
OH /\CN 
1.25 eq per OH 
1 33% 
O CN CN MeOH, HoCl, re?ux 
HZN o 55 4) 
O CN 
Intermediate 1 
COZMe 
O 
Et3N, THF 
H2N4€Ok COZMe —> 
O \ 4Q SOZCl 
COZMe 
Intermediate 2 
COZMe 
NHZOTMS 
(I? o MeOH 
H 
s —N o“ COZMe KOH 
H 00H 
0 O MeOH 
COZMe 
Intermediate 3 
CONHOH 
(i o 
H 
O O 
CONHOH 
Ligand 1 
Synthesis of Intermediate 1 
To a stirred solution of tris(hydroxymethyl)aminomethane 
(50.0 g, 412.0 mmol) and KOH (2.3 g, 4.5% ofthe Weight of 
alcohol) in 1,4-dioxane(150 mL) Was added acrylonitrile 
(71.17 g, 1342.4 mmol) drop Wise over a period of1 h, after 
Which a clear solution Was obtained. After stirring at room 
temperature for 24 h, the mixture Was made acidic (~pH:2) 
by the addition of dil. HCl. After extraction With CH2Cl2 
(3x100 mL) the combined organic layers Were dried over 
sodium sulfate and evaporated to give tris[(cyanoethoxy)me 
thyl]aminomethane (Intermediate 1), 43:2 g (33.5%). IR 
(neat) 3588, 3368, 2251 cm“; 1H NMR (CDCl3) 6 3.68 (t, 
1:60 HZ, 6H), 3.44 (s, 6H), 2.61 (t, 1:60 HZ), 1.68 (br s, 2H); 
13C NMR (CDCl3) 6 118.2, 72.7, 65.9, 56.3, 19.0; HMS (El, 
MH") calcd for Cl3H2lN4O3: 281.16147, found: 281.16138. 
(NeWkome, G. R. and X. Lin, Symmetrical, four-directional, 
POlJ/(Ell’lEF-dn’lld?) cascade polymers. Macromolecules, 
1991. 24(6): p. 1443-1444. 
Synthesis of Intermediate 2 
Dry HCl gas Was passed through a solution of intermediate 
1 (52.6 g, 187.0 mmol) in dry methanol (150 mL) until the 
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solution Was saturated With HCl. The mixture Was re?uxed 
overnight. After the solution Was cooled, NH4Cl Was 
removed by ?ltration, and the ?ltrate Was concentrated to give 
a gum. The gum Was taken up in THF, ?ltered, and the ?ltrate 
Was concentrated to get the tris ester (Intermediate 2) 37.0 g 
(55.0%). IR (neat) 3394, 1735 cm'l; 1H NMR (CDCl3) 6 3.69 
(t, 2Jh_h:6.31 Hz, 6H), 13C NMR (CDCl3) 6 172.4, 69.0, 67.1, 
59.6, 52.0, 34.7; HMS (El, MH") calcd for CI6H3ONO9: 
380.19217, found: 380.19205. (Nierengarten, J. F.; Habicher, 
T.; Kessinger, R.; Cardullo, F., Djuederich, F.; Gramlich, V.; 
Gisselbrecht, J. P.; Boudon, D.; Gross, M., Macrocylization 
on the fullerene core. Direct regio- and diasterioselective 
multi-functionalization of [60]fullerene, and synthesis of 
fullerene-dendrimer derivatives. Helv. Chim. Acta, 1997, 80: 
2238-2276). 
Synthesis of Intermediate 3 
To a stirred solution of tosyl chloride (10.0 g, 52.4 mmol) 
and the tris ester (Intermediate 2) (19.90 g, 52.4 mmol) in 
CH2Cl2 Was added NEt3 (6.37 g, 62.9 mmol) and the mixture 
Was heated at re?ux overnight. The solvent Was removed in 
vacuo, and the residue Was redissolved in CH2Cl2 (200 mL) 
and Washed With Water (3x100 mL). The organic layer Was 
dried over NaZSO4 and concentrated to give a gum. Column 
chromatography using silica gel With 50% ethyl acetate in 
hexane yielded a gummy solid of Intermediate 3 (20.4 g, 
73%), Which later crystallized on storing at room tempera 
ture. Finally it Was characterized by X-ray crystallography. IR 
(neat) 3610, 3287, 1736 cm“; 1H NMR (CDCl3) 6 7.78, 7.76, 
7.27, 7.24 (s each, 4H), 3.68 (s, 9H), 3.51 (s, 6H), 3.51 
(t, 2Jh_h:6.5 Hz, 6H), 2.41 (t, 2Jh_h:6.5 Hz, 6H) 2.41 (s, 3H); 
l3CNMR(CDCl3)6172.1, 142.8, 140.5, 129.2, 127.0, 69.9, 
66.7, 62.4, 51.9, 34.7, 21.6; HMS (El, MH+) calcd for 
C23H36NOUS: 534.20095, found: 534.20093. 
Synthesis of Ligand 1 
To a stirred solution of the tris(ester) (Intermediate 3) (8.23 
g, 15.4 mmol) in methanol (100 mL) Was added NHZOTMS 
(9.74 g, 92.5 mmol) folloWed by KOH (2.60 g, 46.0 mmol); 
1. NaH, 
OMe 
OMe 
‘:1 R: H HOXOH 3 
. 
2. HCl, MeOH
2. R I Boc RHN OH 
B0020 
MeOH 
2. MeOH, HCl 
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After 6 h at room temperature, the reaction mixture Was 
treated With 20 g of preWashed Amberlyst-15 and sWirled for 
1 h. The resin Was ?ltered off and the ?ltrate Was evaporated 
to give a gum. Recrystallization from acetone:hexane (1:1) 
yielded the tris hydroxamate (Ligand 1), 5.02 g, (61%) Which 
Was characterized by X-ray crystallography. IR (neat) 3184, 
1631 cm“; 1H NMR (CDCl3) 6 7.76, 7.73, 7.42, 7.39 (s each, 
4H), 3.46 (t, 1:58 Hz, 6H), 3.40 (s, 6H), 3.31 (s, 3H, MeOH), 
2.40 (s, 3H), 2.30 (t, J :58 Hz, 6H); 13C NMR (CDCl3) 6 
171.1, 145.0, 139.0, 130.1, 127.0, 69.2, 67.0, 63.0, 49.2 
(CH3OH), 33.3, 21.0 HMS (El, MH") calcd for 
C2OH33N4OUS: 537.18677, found: 537.18665. 
EXAMPLE 2 
Synthesis of Ligand 2 
The overall synthesis of Ligand 2 is shoWn in Scheme 6. 
The trimethyl orthoester of 4-iodo-1-butyric acid (3), in 
Which the vulnerable sp3 carbon has been protected, is knoWn 
to alkylate alkoxides (Srivastava, R. P., Hajda, J. Stereospe 
ci?c synthesis of ether phospholipids. Preparation of l -O-(3' 
carboxypropyl)-glycero-3 -phosphoserinefrom glyceric acid. 
Tetrahedron Lett. 1991, 32, 6525-6528) (Method A). Thus 
treatment of the BOC-protected triol (2) With sodium hydride 
and the trimethyl ortho ester (3) in DMF, folloWed by depro 
tection With anhydrous methanolic HCl gives the triester (In 
termediate 4). Alternatively, reductive alkylation of the trim 
ethylsilylated triol (BSA, re?ux) With 
3-cyanopropionaldehyde (IWanami, K., Kentaro Y., Takeshi, 
O. An E?icient and Convenient Methodfor the Direct Con 
version ofAlkyl Silyl Ethers into CorrespondingAlkyl Ethers 
Catalyzed bylron (HI) Chloride. Synthesis 2005, 2669-2672) 
(Method B), folloWed by treatment With anhydrous HCl in 
re?uxing methanol should also yield intermediate 4. Interrne 
diate 4 is tosylated to give Intermediate 5, Which is then 
converted to the corresponding hydroxamic acid (Ligand 2) 
by treatment With O-(trimethylsilyl)hydroxylamine) 
COZMe 
MethodA < 
o o/—\— COZMe Et3N, THF 
—) >( o 
HZN || 
0 co M _ 
MethodB \_/_ 2 e C1 
0 
Intermediate 4 
GCOZMe 
O 
O 
Intermediate 5 
NHZOTMS MeOH KOH 
AcOH MeOH 
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EXAMPLE 3 
Synthesis of Ligand 3. 
The overall synthesis of Ligand 3 is shoWn in Scheme 7. 
Treatment of the BOC-protected triol (2) With sodium 
hydride and the trimethyl ortho ester or 5-iodo-l-pentanoic 
acid (4) in DMF, followed by deprotection With anhydrous 
methanolic HCl gives the triester (Intermediate 6). Alterna 
tively, reductive alkylation of the trimethylsilylated triol 
(BSA, re?ux) With 4-cyanobutryoaldehyde (IWanami, K., 
US 7,932,326 B2 
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-continued 
CONHOH 
Ligand 2 
Kentaro Y., Takeshi, 0. An E?icient and Convenient Method 
15 for the Direct Conversion ofAlkyl Silyl Ethers into Corre 
sponding Alkyl Ethers Catalyzed by Iron (HI) Chloride. Syn 
thesis 2005, 2669-2672) (Method B), followed by treatment 
With anhydrous HCl in re?uxing methanol should also yield 
20 intermediate 6. Intermediate 6 is tosylated to give Intermedi 
ate 7, Which is then converted to the corresponding hydrox 
amic acid (Ligand 3) by treatment With O-(trimethylsilyl) 
hydroxylamine) 
Schemel 
l. NaH, 
OMe 
no on 4 
B0020 1- R I H — Method A 
MeOH 2_ R I B00 2. HCl, MeOH 
RHN on 
1. F6013, Et3SiH, 
H(O—)CCH2CH2CN M?thod B 
2. M?on, HCl 
COZMe 
Et3N, THF 
/\/\/CO2Me 
0 X0 SOZCl 
Intermediate 6 
COZMe 
O/\//\\//\/CO2Me NHZOTMS, MeOH, KOH 
(i 0 AcOH MeOH 
S — N 
H H 
COZMe 
Intermediate 7 
ol 
0 
CONHO H 
CONHOH 
Ligand 3 
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EXAMPLE 4 
Synthesis of Ligand 4. The binding constants for Ligand 1 
(see below) indicate that tWo arms of the ligand bind to metal 
ions very strongly, but that steric hindrance Weakens the 
binding of the third arm. In the heteropodal Ligand 4, the 
length of tWo of the ligand arms have been extended to relieve 
this internal strain. The synthesis of ligand 4 is shoWn in 
Scheme 8. To prepare heteropodal trihydroxamic ligands, tWo 
of the hydroxyls on the aminotriol(tris) are ?rst blocked by a 
protecting group. The aminotriol (1) is converted to the 
knoWn cyclic acetal (5) using a published 2 step, 1 pot pro 
cedure (Ooi, H., Ishibashi, N., IWabuchi, U., Ishihara, J ., 
Hatakeyama, S. A concise Route to (+)-Lactacystin. J. Org. 
Chem. 2004, 69, 7765-7768). Alternatively, the diol can be 
protected as the benZylidene (6a) (Balakumar, V., A highly 
regio- and chemoselective reductive cleavage of benzylidene 
acetals with EtAlCl2-Et3SiH, Synlet, 2004, 647-650; LoW, J. 
N., B. F. Milne, J.-N. Ross, and J. L Wardell, Derivatives of 
N,N’-bis[2-Hydroxy-l,1-bis(hydroxymethyl)ethyU 
ethanediamide. Journal of the Brazilian Chemical Society, 
2002, 13: 207-217) using similar reaction conditions, Which 
results in additional options for deprotection later in the syn 
thetic sequence. Addition of the remaining free alcohol to 
acrylonitrile yields the mononitrile (7) (NeWkome, G. R., Lin, 
X. Symmetrical, four-directional, poly(ether-amide) cascade 
polymers. Macromolecules. 1991, 24, 1443-1444). Simulta 
neous deprotection of the acetal and methanolysis of the 
nitrile With a re?uxing solution of methanolic HCl yields the 
monoester-diol (8). The diol is then alkylated by the addition 
of the trimethyl ortho ester of 5-iodopentanoic acid to form 
the triester (Intermediate 8). An additional complication in 
the alkylation of the monoester diol is base-catalyZed beta 
elimination of the alkoxy group beta to the ester. Intermediate 
8 is tosylated to give Intermediate 9, Which is converted to the 
corresponding trihydroxamate (Ligand 4) by the addition of 
O-(trimethylsilyl)hydroxylamine. 
Scheme 8 
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-continued 
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OXOH 2. H01, MeOH 
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(COZMe 
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SOZCI 
COZMe 
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O O MeOH 
COZMe 
Intermediate 9 
( CONHOH 
O CONHOH 
O 0 
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CONHOH 
Ligand 4 
EXAMPLE 5 
Synthesis of Ligand 5. The synthesis of the heteropodal 
Ligand 5 is described in Scheme 9. The extension of one arm 
of the ligand is achieved by the reaction of the acetal protected 
aminotriol (5) With chloroacetic acid, folloWed by selective 
reduction of the carboxylic acid and deprotection of the cyclic 
acetal to give the unsymmetric triol (9). Adding the triol to 
acrylonitrile gives the trinitrile Intermediate 10, and metha 
nolysis of the nitrile gives the tris(ester) (Intermediate 11). 
This compound is tosylated to give Intermediate 12. The 
addition of O-(trimethylsilyl)hydroxylamine to Intermediate 
12 gives the heteropodal Ligand 5. 
Scheme 9 
HO O NaH, c1cH2co2H 
4’
HN >< 
o 
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EXAMPLE 6 
Synthesis of Ligand 6 
The synthesis of Ligand 6 is shown in Scheme 10. The diol 
(8) from Scheme 8 is reprotected at the amine With a Boc 
22 
group to give (10). The remaining hydroxyls are reductively 
alkylated With aldehyde (1 1) followed by methanolysis to 
yield the triester (Intermediate 13). The aldehyde (11) is 
easily prepared in tWo steps from glycol. Although synthesis 
of the ester (12) Would provide a more direct approach, the 
reaction Would be complicated by competing, rapid lacton 
iZation to lactone (13). Intermediate 13 is tosylated to give 
intermediate 14. This compound is treated With O-(trimeth 
ylsilyl)hydroxylamine to give the heteropodal trishydrox 
amic acid Ligand 6. 
S cheme l O 
COZMe 
< \_/ CN 
0 OH +, 
> < 2. HCl, MeOH, re?ux 
RHN OH 
COZMe 
COM < / \J ” 
OX0 O H N O O 
\_/ 
l. Glycol 
(l 0 equiv.), 
NaH 
CICHZCN 
2 
COZMe 
Intermediate 13 
HO O —\ 
\_/ CN 
11 
Intermediate l3 
O CO M6 NHZOTMS. 
O / \ / 2 MeOH 
|| 0 O ’ 
S _ N KOH 
H H O O AcOH 
O \ MeOH 
50 \_/ COZMe 
Intermediate l4 
K\CONHOH 
o CONHOH 
55 o / \ 
H 
O O O 
CONHOH 
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EXAMPLE 7 
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Synthesis of Ligand 7. The overall synthesis of Ligand 7 is 
shoWn in Scheme 11. 
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Scheme 1 1 
OH 
CH3 dioxane, KOH (cat) 
—>
1.25 eq per OH 
33% 
OH 
CN 0 
CH3 MeOH, rrcr, re?ux 
HZN —>
55% 
0 CN 
Intermediate 15 
COZMe 
Et3N, THF 
\ SOZCI 
COZMe 
Intermediate 16 
COZMe 
/ NHZOTMS 
(i o MeOH 
H 
s —N CH3 KOH 
I AcOH 
O O MeOH 
COZMe 
Intermediate 17 
CONHOH 
0 CH3 0 
H H 
?— N 
O O 
CONHOH 
Ligand 7 
Synthesis of Intermediate 15 
To a stirred solution of 2-amino-2-methyl-1 ,3-propanediol 
(50.0 g, 475.5 mmol) and KOH (1.0 g, 2% of the Weight of 
diol) in 1,4-dioxane (100 mL) Was added acrylonitrile (56.7 g; 
1070.0 mmol) dropWise over a period of 1 h, after Which a 
clear solution Was obtained. After stirring at room tempera 
ture for 24 h, 200 mL of CH2Cl2 Was added to the mixture. 
The mixture Was extracted With Water and the organic layer 
Was dried over sodium sulfate. The solvent Was evaporated to 
yield a thick oil. Distillation under reduced pressure (160 
>C/ 10 mm Hg) yielded Intermediate 15, 39.5 g (39%). IR 
(neat) 3517, 3360, 2250 cm_l; 1H NMR (CDCl3) 6 3.68 (t, 
1:61 HZ, 4H), 3.33 (Abq, Av:14.2 HZ, 1:85 HZ, 4H), 2.60 
(t, 1:61 HZ, 4H), 1.44 (br s, 2H), 1.06(s, 3H; 13C NMR 
(CDCl3) 6 118.2, 76.5, 65.8, 52.8, 22.6, 19.0 HMS (El, MH") 
calcd for ClOHl8N3O2: 212.14002, found: 212.13989. 
Synthesis of Intermediate 16 
Dry HCl gas Was passed through a solution of Intermediate 
16 (39.48 g, 186.1 mmol) in dry methanol (150 ml) until the 
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solution Was saturated With HCl. The mixture Was re?uxed 
overnight. After cooling, NH4Cl Was removed by ?ltration, 
and the ?ltrate Was concentrated to give a gum. The gum Was 
redissolved in THF, ?ltered, and the ?ltrate Was concentrated 
to get the diester (Intermediate 16) 30.0 g (57.0%). IR (neat) 
3409, 1727 cm_l; 1H NMR (CDCl3) 6 3.79 (t, 1:61 HZ, 2H), 
3.70 (2, 6H), 3.62 (s, 4H), 2.64 (t, 1:61 HZ, 4H), 1.42 (s, 3H); 
13C NMR (CDCl3) 6 172.6, 71.7, 67.2, 58.0, 52.1, 34.8, 18.4; 
HMS (El, MH") calcd for C12H24NO6: 278.16047, found: 
278.16037. 
Synthesis of Intermediate 17 
To a stirred Solution of tosyl chloride (10.0 g, 52.4 mmol) 
and Intermediate 16 (14.54 g, 52.4 mmol) in CH2Cl2 Was 
added NEt3 (6.37 g, 62.9 mmol) and the mixture Was heated 
at re?ux overnight. The solvent Was removed in vacuo, and 
the residue Was redissolved in CH2Cl2 (200 mL) and Washed 
With Water (3x100 mL). The organic layer Was dried over 
NaZSO4 and concentrated to give a gum. Column chromatog 
raphy using silica gel With 40% ethyl acetate in hexane 
yielded a gummy solid of Intermediate 17, (16.9 g, 74%). IR 
(neat) 3604, 1736, 1735 cm“; 1H NMR (CDCl3) 6 7.82, 7.55, 
7.29, 7.26 (s each, 4H), 3.70 (s, 6H), 3.65 (t, 1:62 HZ, 4H), 
3.33 (Abq, Av:47.0 HZ, 1:91 HZ, 4H), 2.53 (t, 1:62 HZ, 
4H), 2.41 (s, 3H), 1.10 (s, 3H); 13C NMR (CDCl3) 6 172.2, 
143.1, 140.7, 129.6, 127.0, 73.7, 66.8, 58.9, 51.9, 34.9, 21.7, 
18.2; HMS (El, MH") calcd for Cl9H3ONO8S: 432.16931, 
found: 432.16922. 
Synthesis of Ligand 7 
To a stirred solution of the ester (Intermediate 17) (3.61 g, 
8.3 mmol) in methanol (50 mL) Was added NHZOTMs (3.52 
g, 33.4 mmol) folloWed by KOH (0.94 g, 16.7 mmol). After 6 
h at room temperature, the mixture Was treated With 7.0 g of 
preWashed Amberlyst-15 and sWirled for 1 h. The resin Was 
?ltered off and the ?ltrate Was evaporated to give a gum. 
Recrystallization from CH2Cl2:ether (1:1) yielded Ligand 7, 
2.46 g, (68%). IR (neat) 3233, 1633 cm_l; 1H NMR (CDCl3) 
6 7,76, 7.68, 7.42, 7.39 (s each, 4H), 3.54 (m, 4H), 3.35 (s, 
4H), 3.30 (Abq, Av:22.6 HZ, J:10.0 HZ, 4H), 2.40 (s, 3H), 
2.34 (t, 1:58 HZ, 6H), 1.08 (s, 3H); 13C NMR (CDCl3) 6 
171.1, 145.0, 139.0, 130.2, 127.0, 73.5, 67.0, 59.5, 493,210, 
18.8; HMS (El, MH") calcd for Cl7H28N3O8S: 434.15983, 
found: 434.15970. 
EXAMPLE 8 
Synthesis of Resin 1. Resin 1 Was prepared by synthesizing 
the chelating functional group (R3:a) Of Ligand 1 on the 
surface of a polystyrene resin. The synthesis of Resin 1 is 
shoWn in Scheme 12. Macro-porous polystyrene beads (14, 
Amberlite XAD-4) Were reacted With chlorosulfonic acid to 
give the polymeric sulfonyl chloride (15) (Emerson, D. W., 
Emerson, R. R., Joshi, S. C., Sorensen, E. M., Turek, J. E. 
Polymer-bound sulfonylhydrazine functionality. Prepara 
tion, characterization, and reactions of copoly(styrene-divi 
nylbenzenesuh‘ionylhydrazine). J. Org. Chem. 1979, 44: 4634 
4640; Hu, J.-B., Zhao, G., Ding, Z.-D. Enantioselective 
reduction of ketones catalyzed by polymer-supported sul 
fonamide using NaBH4/Me3SiCl (orBF3 *OEt2) as reducing 
agent. AngeWandte Chemie, International Edition 2001, 40: 
1109-1111). The procedures in Scheme 5 Were used to pre 
pare the methyl ester of the free amine form of ligand 1 
(Intermediate 2). Addition of Intermediate 2 to the sulfonyl 
chloride form of the resin (15) gave the sulfonamide triester 
(Intermediate 18). The ester functional groups Were con 
verted to hydroxamic acids by reaction With O-trimethylsilyl 
hydroxylamine in methanol to give Resin 1. The successful 
conversion of the esters to hydroxamic acids Was judged from 
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the IR spectra. The number of ligand molecules on the surface 
of the resin Was calculated from the S and N combustion 
analysis of the resin to be 0.3 mmoles ligand per gram of 
resin. 
Scheme 12 
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Synthesis of Sulfonyl Chloride Resin: 
To 35 g of macroporous styrene-divinylbenZene, copoly 
mer (20-60 mesh, avg. pore diameter: 40 A, Amberlite XAD 
4) in 100 mL of 1,2-dichloroethane Was added 160 g (1.37 
mol) of technical grade chlorosulfonic acid With occasional 
sWirling. The mixture Was kept at room temperature for 12 h. 
The product Was ?ltered using a glass frit and Was Washed 
successively With tWo portions of dichloromethane (DCM), 
tWo portions of DCM-THF mixture, tWo portions of THF, and 
a ?nal Wash With DCM. The vacuum dried polymer Was ready 
to use and Was stored under argon at loW temperature. IR 
(neat) 3521, 1369, 1171 cm“; Anal. Found: C, 57.17; H, 
5.50; S, 10.23; Cl, 8.49; calculated loading S, 3.22 mmol/g, 
Cl, 2.39 mmol/g. 
Synthesis of Intermediate 18 
To polymeric sulfonyl chloride (15) (2.0 g, 5.0 mmol) in 
THF (50 mL) Was added a solution of the tris ester of the free 
ligand (Intermediate 2) (7.58 g, 20.0 mmol) in THF (30 mL) 
folloWed by triethylamine (2.0 g, 20.0 mmol) and the mixture 
Was sWirled for four days at room temperature. The polymer 
Was then ?ltered off and Washed successively With THF, 
Water, THF, DCM and dried in vacuo. IR (neat) 3494, 1732, 
1169 cm_l;Anal. Found: C, 58.96; H, 6.81; S, 8.22; N, 2.66; 
calculated loading: S, 2.57 mmol/g, N, 1.90 mmol/g. 
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Synthesis of Resin 1 
To the resin-bound triester (Intermediate 18) (1.7 g, 4.25 
mmol) in methanol (40 mL) Was added NHZOTMs (4.02 g, 
38.2 mmol) dropWise With stirring at room temperature. KOH 
(2.14 g, 38.2 mmol) Was added and the mixture Was sWirled 
for 12 h. The product, resin 1, Was ?ltered off and Washed 
successively With methanol, Water, and methanol. The resin 
Was then sWirled With dil. acetic acid for an hour and Washed 
successively With methanol, Water, THF, and dried Over 
pump. IR (neat) 3479, 1644, 1173 cm_l; Anal. Found: C, 
54.65 H, 5.57; S, 9.51; N, 1.59; Loading: S, 2.97 mmol/g, N, 
1.14 mmol/ g. 
EXAMPLE 9 
Synthesis of Resin 2. The overall synthesis of Resin 2 is 
shoWn in Scheme 13. 
Scheme 13. 
owcozMe 
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Synthesis of Intermediate 19. The synthesis of the chloro 
sulfonated polystyrene resin (15) is described in Scheme 12. 
To this polymeric sulfonyl chloride (5.2 g, 13.0 mmol) in THF 
(80 mL) Was added a solution containing Intermediate 16 
from Scheme 11, (14.4 g, 52.0 mmol) in THF (50 mL) fol 
loWed by triethylamine (5.26 g, 52.0 mmol). The suspension 
Was sWirled for four days at room temperature. The product, 
Intermediate 19, Was then ?ltered off and Washed succes 
sively With THF, Water, THF, DCM and dried over pump. IR 
(neat) 3492, 1735, 1170 cm_l; Anal. Found: C, 60.28; H, 
7.04; S, 8.42; N, 2.61; calculated loading: S, 2.63 mmol/g, N, 
1.86 mmol/ g. 












